CompoundingGain

First Oral approved favipiravir medication for COVID

NSE:GLENMARK   GLENMARK PHARM


Sitting just under resistance at 421 expect this to be taken out on open and the retest IF it happens is a good spot to load up.

Recon this should fly to 574 then get knocked back a bit for a while before flying up with more power .

Might be wrong and the FOMO on this may keep blasting it up , the downtrend line is not that far off so all indicators should turn into buy once that is taken out .

Lets see ..

면책사항

이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.